Trial intelligence / Profile preview

Oral midazolam solution for preoperative anxiety and postoperative agitation in pediatric TEP surgery

ChiCTR2600124292Phase 4Not yet recruiting

Sponsor
Meishan City People's Hospital
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of midazolam in inguinal hernia (2 arms), sponsored by Meishan City People's Hospital. Primary endpoint: Modified Yale Preoperative Anxiety Scale (m-YPAS) score. Planned start May 2026; status: not yet recruiting.

02

Drugs

midazolam
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on ChiCTR2600124292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600124292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call